Aiderus Aziz, Contreras-Sandoval Ana M, Meshey Amanda L, Newberg Justin Y, Ward Jerrold M, Swing Deborah A, Copeland Neal G, Jenkins Nancy A, Mann Karen M, Mann Michael B
Department of Molecular Oncology, Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.
Cancer Research Program, Houston Methodist Research Institute, Houston, TX 77030, USA.
Cancers (Basel). 2021 Jan 9;13(2):225. doi: 10.3390/cancers13020225.
A central challenge in cancer genomics is the systematic identification of single and cooperating tumor suppressor gene mutations driving cellular transformation and tumor progression in the absence of oncogenic driver mutation(s). Multiple in vitro and in vivo gene inactivation screens have enhanced our understanding of the tumor suppressor gene landscape in various cancers. However, these studies are limited to single or combination gene effects, specific organs, or require sensitizing mutations. In this study, we developed and utilized a transposon mutagenesis system that functions only as a gene trap to exclusively inactivate tumor suppressor genes. Using whole body transposon mobilization in wild type mice, we observed that cumulative gene inactivation can drive tumorigenesis of solid cancers. We provide a quantitative landscape of the tumor suppressor genes inactivated in these cancers and show that, despite the absence of oncogenic drivers, these genes converge on key biological pathways and processes associated with cancer hallmarks.
癌症基因组学的一个核心挑战是在没有致癌驱动基因突变的情况下,系统地识别驱动细胞转化和肿瘤进展的单个及协同作用的肿瘤抑制基因突变。多项体外和体内基因失活筛选增强了我们对各种癌症中肿瘤抑制基因格局的理解。然而,这些研究仅限于单个或组合基因效应、特定器官,或者需要敏化突变。在本研究中,我们开发并利用了一种转座子诱变系统,该系统仅作为基因陷阱发挥作用,专门使肿瘤抑制基因失活。通过在野生型小鼠中进行全身转座子动员,我们观察到累积的基因失活可驱动实体癌的肿瘤发生。我们提供了这些癌症中失活的肿瘤抑制基因的定量格局,并表明,尽管没有致癌驱动因素,但这些基因汇聚于与癌症特征相关的关键生物学途径和过程。